Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors [PDF]
, 2017 Cytotoxic T-lymphocyte-associated protein-4, programmed cell death protein and programmed cell death protein ligand 1 monoclonal antibodies (immune checkpoint inhibitors), are used to treat various malignancies.
Belum, V R +8 more
core
Viral-Induced Rapidly Progressive Alopecia Universalis: A Case Report and Literature Review. [PDF]
Cureus, 2023 Alotaibi MA +3 more
europepmc +1 more source
Alopecia Universalis with Dystrophy of the Nails [PDF]
Proceedings of the Royal Society of Medicine, 1912 openaire +2 more sources
Complete regrowth of hair following scalp tattooing in a patient with alopecia universalis. [PDF]
JAAD Case Rep, 2023 Ramnot A, Resnik S, Resnik B.
europepmc +1 more source
Possible mechanisms mediating complete regrowth of hair following scalp tattooing in alopecia universalis. [PDF]
JAAD Case Rep, 2023 Homolak J.
europepmc +1 more source
Topical Ruxolitinib for the Treatment of Alopecia Universalis [PDF]
JAMA Dermatology, 2016 Brittany G, Craiglow +2 more
openaire +2 more sources
Refractory alopecia universalis associated with dermatomyositis successfully treated with tofacitinib. [PDF]
Mod Rheumatol Case Rep, 2022 Castillo R, Albayda J.
europepmc +1 more source
Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis. [PDF]
Ther Adv Neurol Disord, 2022 Tzanetakos D +10 more
europepmc +1 more source
Resolution of Hashimoto thyroiditis with Janus kinase inhibitor therapy in a patient with alopecia universalis. [PDF]
JCEM Case RepTrost SU, Radulescu A.
europepmc +1 more source